Here’s Why Alnylam Pharmaceuticals (ALNY) Declined
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
AMH fertility tests surge but cannot predict natural pregnancy
Increasing numbers of Australian women are using a blood test to assess their fertility, but new research suggests it may not provide the answers many are looking for.
NHS reports busiest ever summer as heatwaves drive up hospital admissions
Health secretary says extreme demand no longer confined to winter as service in England warns of knock-on effects The NHS faced the “busiest summer in its history” as the UK experienced a series of…
Bipasha Basu says she found worms in a new Isopure container, calls on Maharashtra's FDA: 'You are our only hope'
Dubai: Bipasha Basu has raised a food-safety concern after saying she found what appeared to be tiny worms inside a newly opened container of the nutrition brand Isopure, and has publicly appealed to…
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.
Inside the UAE ‘flying ICU’ transporting critically ill patients worldwide
A UAE-based aeromedical service has completed nearly 1,000 flying hours across 20 countries and five continents in its first five months of operation, transporting critically ill patients who require…
A booming business on Wall Street would love more biotechs to quietly die
Once disparaged, reverse mergers have become so popular that some deal experts question whether there are enough quality shell companies to meet the demand.